TherapeuticsMD (TXMD) Depreciation and Depletion (2010 - 2022)
TherapeuticsMD (TXMD) posted Depreciation and Depletion of $200000.0 for Q4 2022, little changed on a QoQ basis from $200000.0 in Q3 2022, and up 200.0% year-over-year from $66666.7 in Q4 2021.
TherapeuticsMD (TXMD) Depreciation and Depletion (2010 - 2022) Analysis & Trends
TherapeuticsMD's Depreciation and Depletion history runs 13 years deep, the most recent figure standing at $200000.0 for Q4 2022.
- Quarterly Depreciation and Depletion rose 200.0% year-over-year to $200000.0 in Q4 2022, while the trailing twelve-month figure through Sep 2023 was $200000.0 (down 33.33% YoY) and the FY2022 annual result came in at $600000.0, up 50.0% from the prior year.
- Depreciation and Depletion was $200000.0 for Q4 2022 at TherapeuticsMD, roughly flat from $200000.0 in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $200000.0 in Q2 2020 and bottomed at -$200000.0 in Q4 2021.
- A 5-year average of $124020.6 and a median of $187625.0 in 2019 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2020 — Depreciation and Depletion soared 200.5% — and 2021, when it plunged 200.0%.
- TherapeuticsMD's Depreciation and Depletion stood at $59989.0 in 2018, then soared by 193.8% to $176250.0 in 2019, then advanced by 13.48% to $200000.0 in 2020, then plunged by 200.0% to -$200000.0 in 2021, then jumped by 200.0% to $200000.0 in 2022.
- Business Quant data shows TXMD's Depreciation and Depletion at $200000.0 in Q4 2022, $200000.0 in Q3 2022, and $200000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | TherapeuticsMD | 280,159.99 | -8.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 200,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Sep 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -200,000.00 |
| Dec 31, 2021 | -200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Mar 31, 2021 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |
| Sep 30, 2020 | 200,000.00 |